To assess the efficacy and safety of meloxicam 7.5mg once daily compared with diclofenac 100mg SR once daily over a treatment period of 8 weeks
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
91
Change from baseline in pain on active movement assessed by a 100 mm visual analogue Scale (VAS)
Time frame: Baseline, 8 weeks after first drug administration
Change from baseline in Lequesne index
Time frame: Baseline, 8 weeks after first drug administration
Change from baseline in global assessment by the patient and doctor on a 3-point scale
Time frame: Baseline, 8 weeks after first drug administration
Number of patients with significant changes from baseline in Laboratory values
Time frame: Baseline, 8 weeks after first drug administration
Number of patients with significant changes from baseline in physical examinations
Time frame: Baseline, 8 weeks after first drug administration
Number of patients with Adverse Events
Time frame: Up to 8 weeks after first drug administration
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.